Login

Geoff Jamieson, Managing Director of Orcoda Limited (ASX: ODA), discusses the partnership with ShareRing Australia Pty Ltd. 00:10:00

Share On Facebook Share On Twitter

Geoff Jamieson is Mng Dir/CEO at Orcoda Ltd.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
From Dropbox to IVP: The CFO Turned VC Investor|Ajay Vashee,General Partner,IVP
00:10:00
Raízen's Ricardo Mussa on Leading Brazil's Largest Energy Conglomerate | Ricardo Mussa, CEO , Raízen SA.
00:10:00
AboitizPower President and CEO Manny Rubio reviews the company's 2023 performance and provides insights in this video.
00:10:00
The Entrepreneurial Journey and Values Beyond Octopus | Simon Rogerson , CEO , Octopus Group .
00:00:00
Antibody-Drug-Conjugates as New Therapeutic Modalities for Cancer Therapy - Prof. Dr. Andreas Pahl Chief Executive Officer, Heidelberg Pharma
00:10:00
Challenges of Green Transformation in European Economy | Paweł Majewsk, CEO, Enea SA.
00:10:00
Zalaris - executive interview | Hans-Petter Mellerud, CEO, Zalaris ASAZAL:OSL
00:10:00
Schwab's Quarterly Update: CEO Will Bettinger's Insights | Walter W Bettinger II, CEO, Charles Schwab Corporation.
00:10:00
Trailblazing Entrepreneur and ANGI Co-Founder | Angie Hicks, Co-Founder, Angi Inc.
00:10:00
Navigating Divorce or Loss: Practical Tips for Managing Financial Tasks
00:10:00
The Cramdown Podcast: Meet O'Melveny's New Dallas Bankruptcy Partners | Lou Strubeck Jr. - Partner, O'Melveny & Myers LLP
00:10:00
only invest in only a few new companies each year|Kee Lock Chua,Managing Partner,Vertex Ventures

© 2026 Nehu